Stay updated on bb2121 vs Standard Regimens in RRMM Clinical Trial

Sign up to get notified when there's something new on the bb2121 vs Standard Regimens in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the bb2121 vs Standard Regimens in RRMM Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    2%
    Check dated 2025-10-06T08:00:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Adds a broader term Multiple myeloma and updates revision to v3.1.0; removes older, more specific Softer terms and an older revision tag (v3.0.2).
    Difference
    0.3%
    Check dated 2025-09-29T04:23:09.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Multiple myeloma.
    Difference
    0.1%
    Check dated 2025-09-22T01:47:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a minor update. The only visible change is the removal of the Back to Top link, with no changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T22:09:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the topic of Multiple myeloma has been removed from the MedlinePlus Genetics section.
    Difference
    0.2%
    Check dated 2025-09-07T19:16:17.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a comprehensive list of publications related to idecabtagene vicleucel and other drugs for plasma cell myeloma. Notably, several drug names have been retained while others have been removed, indicating a focus on specific treatments.
    Difference
    11%
    Check dated 2025-08-31T12:38:44.000Z thumbnail image

Stay in the know with updates to bb2121 vs Standard Regimens in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the bb2121 vs Standard Regimens in RRMM Clinical Trial page.